ANALYSIS OF KRAS MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAZILIAN PATIENTS

被引：0
|
作者：
Couto, Patricia G. P. [1 ]
Bastos-rodrigues, Luciana [1 ]
Sabato, Cristina [1 ]
Guieiro, Fernanda [1 ]
Vilhena, Alyne [2 ]
Amaral, Nilson F. [2 ]
De Marco, Luiz [1 ]
机构：
[1] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[2] Hosp Julia Kubitscheck, Belo Horizonte, MG, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
INDELS; NSCLC; Kras;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S735 / S736
页数：2
相关论文
共 50 条
  • [41] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Zhi-min
    An, She J.
    Wu, Yi-long
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S458 - S458
  • [42] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Z. -M.
    An, S. -J.
    Huang, L.
    Wu, Y. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 48 - 48
  • [43] Targeting KRAS in Non-Small Cell Lung Cancer
    Corral de la Fuente, Elena
    Olmedo Garcia, Maria Eugenia
    Gomez Rueda, Ana
    Lage, Yolanda
    Garrido, Pilar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [44] Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
    Sun, Jong-Mu
    Hwang, Deok Won
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    PLOS ONE, 2013, 8 (05):
  • [45] PD-L1 expression, EGFR and KRAS mutations in unresectable stage III non-small cell lung cancer (NSCLC) patients
    Cronin-Fenton, Deirdre
    Dalvi, Tapashi
    Hedgeman, Elizabeth
    Norgaard, Mette
    Pedersen, Lars
    Hansen, Hanh
    Fryzek, Jon
    Walker, Jill
    Mellemgaard, Anders
    Rasmussen, Torben
    Shire, Norah
    Riggas, James
    Potter, Danielle
    Hamilton-Dutoit, Stephen
    Sorensen, Henrik
    CANCER RESEARCH, 2018, 78 (13)
  • [46] PROGNOSTIC AND PREDICTIVE VALUE OF KRAS MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Hwang, Deok Won
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1075 - S1075
  • [47] KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer
    Eklund, Ella A.
    Wiel, Clotilde
    Fagman, Henrik
    Akyurek, Levent M.
    Raghavan, Sukanya
    Nyman, Jan
    Hallqvist, Andreas
    Sayin, Volkan, I
    CANCERS, 2022, 14 (09)
  • [48] Evaluation of non-small cell lung cancer (NSCLC) tumour sample requirements for EGFR and KRAS mutation analysis
    Morgan, Shethah
    Donald, Emma
    Ryan, Anderson
    Kockx, Mark
    Verstrepen, Walter
    Tepperberg, James
    ANNALS OF ONCOLOGY, 2011, 22 : 26 - 26
  • [49] Multivariate survival analysis of patients with operable non-small cell lung cancer (NSCLC)
    Akkoclu, A
    Onen, A
    Sanli, A
    Sengün, B
    Karacam, V
    Kargy, A
    Yylmaz, E
    Ytil, O
    LUNG CANCER, 2005, 49 : S344 - S344
  • [50] Prevalence of KRAS Subtype Alterations in Non-Small Cell Lung Cancer (NSCLC) with Brain Metastases
    Karim, N. Abdel
    Polani, F.
    Se, B.
    Macera, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S246 - S246
12345